Report: Purdue Pharma Testing Effects of OxyContin on Kids in Effort to Extend Patent by Six Months [Think Of The Children]

The pharmaceutical company behind OxyContin is paying dozens of clinical sites to document the effects of the highly addictive painkiller on children as part of an effort to secure a Food and Drug Administration approval to label the drug for use by kids ages six and up, according to a report published by The Daily. More »